Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MedMira Inc MMIRF


Primary Symbol: V.MIR

Healthcare Medical Devices
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely... see more

Recent & Breaking News (TSXV:MIR)

MedMira Unaware of Any Material Change

Marketwired March 9, 2017

MedMira Announces AGM Results and Stock Option Grant

Marketwired January 30, 2017

MedMira Reports 2017 First Quarter Financial Results

MarketWire Canada December 30, 2016

MedMira Reports 2016 Fourth Quarter and Year End Financial Results

MarketWire Canada November 28, 2016

MedMira Reports FY2016 Third Quarter Results

MarketWire Canada June 29, 2016

MedMira Reports Second Quarter Results for FY2016

Marketwired March 24, 2016

MedMira Announces Departure of Board Director

Marketwired March 3, 2016

MedMira Announces Annual Shareholders Meeting Results

Marketwired February 1, 2016

MedMira Directors Granted Stock Options

Marketwired January 8, 2016

MedMira Reports Fiscal First Quarter 2016 Financial Results

Marketwired December 14, 2015

MedMira Debuts Reveal(R) G4 Rapid HIV Test at National HIV Prevention Conference

Marketwired December 7, 2015

MedMira Reports 2015 Fourth Quarter and Year End Financial Results

Marketwired November 24, 2015

MedMira Receives FDA Approval for the Reveal(R) G4 Rapid HIV-1 Antibody Test

Marketwired October 19, 2015

IIROC Trading Halt - MIR

Canada NewsWire October 19, 2015

IIROC Trade Halt - Medmira Inc.

Newsfile October 19, 2015

MedMira Closes Investment from OnSite Lab

Marketwired September 8, 2015

MedMira Targets Technology Promotion with Latest Investment from OnSite Lab

Marketwired September 2, 2015

MedMira Board Reinforces Biotech Bench Strength with New Appointment

Marketwired August 17, 2015

MedMira Opens US Subsidiary in Atlanta, GA

Canada NewsWire July 20, 2015